The CPS1 gene helps your liver turn ammonia, a waste chemical made when your body breaks down protein, into urea so it can leave in urine. This gene plays an important role in keeping ammonia at safe levels. If it does not work well, ammonia can build up in the blood and affect the brain. Rare disease-causing variants in the CPS1 gene can lead to CPS1 deficiency, which often starts in newborns with poor feeding, vomiting, unusual sleepiness, or seizures, although some people develop symptoms later.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, and medications. For a deeper look at this subject, you can learn more in the LearnHub.
Overview
CPS1Gene function
What if the gene works
The CPS1 gene helps the liver turn ammonia, a waste product from protein breakdown, into urea so it can leave the body in urine. This supports safe nitrogen balance.
Risk
What if the gene does not work
More severe variants in the CPS1 gene often cause CPS1 deficiency, a urea cycle condition that can lead to ammonia buildup, poor feeding, vomiting, sleepiness, seizures, or coma. Milder variants may cause later, more variable episodes.
Treatment
What does that mean for your treatment
Pathogenic variants in the CPS1 gene usually mean treatment centers on preventing and quickly lowering ammonia. Long term care often includes a carefully managed low protein diet, citrulline, and nitrogen scavenging medicines such as sodium benzoate or glycerol phenylbutyrate. In severe or hard to control cases, liver transplant can be part of management.
Conditions associated with CPS1
Gene function
What if the gene works
Each day, your liver turns leftover nitrogen from protein into a form your body can safely remove. The CPS1 gene gives liver cells instructions for a key enzyme that works inside mitochondria, the cell parts that handle energy and other vital tasks. This is a central part of how the CPS1 gene helps remove ammonia from the body.
CPS1 starts the process that turns ammonia, a waste product from normal protein breakdown, into a safer substance. This helps the body prepare that waste for removal in urine.
The CPS1 gene provides the first major step of the urea cycle, the liver's main pathway for clearing extra nitrogen. It uses ammonia, bicarbonate, and ATP (cell energy) to make carbamoyl phosphate.
This enzyme works inside mitochondria, where liver cells carry out part of their chemical processing. That placement supports steady ammonia handling during everyday metabolism.
CPS1 responds to a natural liver signal that switches the enzyme on when ammonia needs to be processed. This helps urea production match the body's normal protein use.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many do not cause any noticeable effects and simply represent natural genetic variation. In some situations, though, a variant can change gene function more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In terms of how variants in the CPS1 gene affect enzyme activity, some alter the enzyme’s shape, stability, or ability to bind its helper molecule, so liver cells struggle to start the pathway that clears ammonia. Milder variants may leave some activity, while more severe variants can nearly or completely shut it down. This functional range often influences whether CPS1 deficiency appears later and more mildly or starts earlier with more marked symptoms.
How variants are linked to conditions
Variants in both copies of the CPS1 gene are linked to carbamoyl phosphate synthetase I deficiency, a rare inherited condition. This CPS1 gene condition often appears in newborns, though some people are diagnosed later after episodes of very high ammonia in the blood. Carrying one CPS1 variant usually does not cause the condition.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some cases, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CPS1, the main factor is inherited risk: a child is affected when they inherit a nonworking CPS1 copy from both parents. In people already living with CPS1-related illness, fasting, infections, high-protein intake, and some medicines can trigger dangerous ammonia buildup. There is not enough evidence to say lifestyle changes can remove the inherited risk itself.
Inheritance of CPS1 variants
CPS1-related carbamoyl phosphate synthetase I deficiency is inherited in an autosomal recessive pattern. This means a child needs to inherit two disease-causing variants in the CPS1 gene, one from each parent, to have the condition. Parents who each carry one CPS1 variant usually do not have the condition themselves, but with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. This is the main pattern that explains how CPS1 variants are inherited in families.
What does my CPS1 result mean for my family?
For families with a disease-causing CPS1 result, close relatives may also carry the same change, even if they feel completely well. Brothers and sisters may be affected or may be carriers, and other relatives may also carry it. This usually matters most for family planning, because two carrier parents can have a child with CPS1-related illness.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CPS1 variants uses a blood or saliva sample to read the CPS1 gene and look for changes linked to carbamoyl phosphate synthetase 1 deficiency. Testing may be done as single-gene sequencing or as part of a larger panel, and some labs also check for missing or extra pieces of the gene.
When should I consider getting a genetic test?
Consider CPS1 genetic testing if there is a family history of CPS1-related illness or if a baby, child, or adult has episodes of very high ammonia in the blood, which can cause vomiting, extreme sleepiness, confusion, or seizures. Testing can help confirm whether CPS1 is the cause.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the specific variant involved. Lifestyle, environment, age, and medical history all help shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best viewed alongside other parts of care. In other situations, it may offer a clear answer. In areas like medication response, a genetic result can also help put individual experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles a medicine, including how quickly it is broken down, moved through the body, or how strongly it acts at its target. That helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect how people respond to medications. It studies gene drug relationships to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how the body handles a drug or how strong its effects are. This information can support treatment choices that are more informed and more individualized. To read more about this subject, more information is available in the LearnHub.
Drugs influenced by the CPS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so medication questions are best discussed with your doctor. Seek medical advice if you have side effects, unexpected reactions, or concerns when starting or changing any medicine.
History
Long before the CPS1 gene was identified, doctors recognized a rare inherited illness in babies and children with very high ammonia levels in the blood. In the second half of the 20th century, work on the urea cycle helped connect that illness to a missing liver enzyme, laying the groundwork for gene discovery. Building on this early work, scientists identified the CPS1 gene in the 1990s and began linking specific variants to carbamoyl phosphate synthetase I deficiency. As DNA testing improved, families could receive a clearer genetic explanation for episodes of poor feeding, vomiting, unusual sleepiness, and coma related to high ammonia. Over time, descriptions became more precise. Today, the CPS1 gene is part of newborn and metabolic genetics discussions because its discovery helped clarify one of the classic inherited causes of hyperammonemia.